Command Palette

Search for a command to run...

Chandra Bhagat Pharma Ltd.
43(+0.00%)
1W: -10.51%

Chandra Bhagat Pharma Quarterly Results

Pros & Cons

POSITIVES
  • Consistent revenue growth over the last four quarters indicates strong demand for products.
  • Improved profit margins this quarter reflect better cost management and operational efficiencies.
  • Increased investment in R&D suggests a commitment to innovation and future product lines.
NEGATIVES
  • Rising raw material costs have negatively impacted profit margins compared to the previous quarters.
  • Declining net income in the latest quarter raises concerns about sustainability of growth.
  • Cash flow issues reported may hinder future investments and operational flexibility.

Quarterly Results Data (Numbers are in Crore)

FieldTrend
Expenses
-
Operating Profit
-
Other Income
-
Tax
-

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.